(HealthDay News) — Inappropriate prescribing of intravenous (IV) fluids most often involves incorrect volumes and types of IV fluids prescribed, according to a review published online June 11 in the ...
(HealthDay News) — Potentially harmful intravenous (IV) fluids are being given to too many patients with severe heart failure, according to a new study published in the Feb. 1 issue of JACC: Heart ...
The US FDA has approved pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck), a subcutaneous version of the intravenous formulation of Keytruda, for adults and children aged 12 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback